Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma.

Krug, Bruno; Crott, Ralph; Roch, Isabelle; Lonneux, Max; Beguin, Claire; Baurain, Jean-François; Pirson, Anne-Sophie; Vander Borght, Thierry

Krug, Bruno; Crott, Ralph; Roch, Isabelle; Lonneux, Max; Beguin, Claire; Baurain, Jean-François; Pirson, Anne-Sophie; Vander Borght, Thierry.

Affiliation

Krug B; Nuclear Medicine Division, Mont-Godinne University Hospital, Université Catholique de Louvain, Yvoir, Belgium. bruno.krug@uclouvain.be

Acta Oncol ; 49(2): 192-200, 2010.

Article in En | MEDLINE | ID: mdl-20059314

Subject(s)

Lung Neoplasms/economics; Melanoma/economics; Positron-Emission Tomography/economics; Skin Neoplasms/economics; Tomography, X-Ray Computed/economics; Cost-Benefit Analysis; Fluorodeoxyglucose F18/economics; Humans; Lung Neoplasms/diagnosis; Lung Neoplasms/secondary; Melanoma/diagnosis; Melanoma/secondary; Radiopharmaceuticals/economics; Skin Neoplasms/diagnosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tomography, X-Ray Computed / Positron-Emission Tomography / Lung Neoplasms / Melanoma Type of study: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Belgium

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google